Skip to main content
4

Module 4 of 12

Biopsy & Excision Techniques

By Dr. Yehonatan Kaplan (M.D., Fellow ACMS)Published: 2026-03-10Updated: 2026-03-10Reviewed: 2026-03-10

Learning Objectives

  • Perform punch, shave, and incisional biopsy techniques with proper specimen handling
  • Design a fusiform excision with appropriate margins and 3:1 length-to-width ratio
  • Manage standing cutaneous deformities (dog ears) using standard techniques
  • Apply C&E protocol with appropriate patient selection

Biopsy Techniques

Biopsy is the gateway procedure of dermatologic surgery. Proper technique ensures accurate diagnosis through adequate tissue sampling at the correct depth, while minimizing artifacts that confuse histopathologic interpretation. The three core biopsy types. Punch, shave, and incisional. Each have distinct indications and technical considerations.

Punch Biopsy

The punch biopsy is a full-thickness sampling technique that obtains a cylindrical core of tissue through the epidermis, dermis, and into the subcutaneous fat. The circular blade is rotated with gentle downward pressure while the skin is stretched perpendicular to the relaxed skin tension lines (RSTLs). This creates an elliptical wound that can be closed with a single suture. Technique: prep and anesthetize the site, stretch the skin perpendicular to RSTLs, rotate the punch with steady downward pressure until loss of resistance (indicating entry into the subcutis), remove the punch, gently elevate the specimen with forceps (avoid crush artifact), and transect the base with scissors. Close with a single suture or allow secondary intention healing for ≤3mm punches.

Key Points

  • The 4mm punch is the workhorse of diagnostic dermatology. Large enough for adequate sampling, small enough for single-suture closure
  • For inflammatory dermatoses, biopsy the most developed (not the newest or oldest) lesion

Clinical Pearls

  • Stretching the skin perpendicular to RSTLs before punching converts the circular defect into an ellipse that closes naturally along tension lines
  • For alopecia workup, two 4mm punches are standard: one for horizontal sectioning, one for vertical sectioning
  • Always submit punch biopsy specimens in formalin with the base down. Improper orientation can lead to tangential sectioning
Punch Biopsy
Punch SizePrimary IndicationsClosure
2mmSmall lesion sampling, dermatitis confirmationSecondary intention or Steri-Strip
3mmMost inflammatory dermatoses, small tumorsSingle suture or secondary intention
4mmStandard diagnostic biopsy, alopecia workupSingle suture
5–6mmPanniculitis (need subcutis), deep tumors1–2 sutures
8mmRarely used; subcutaneous pathology2 sutures, consider elliptical excision instead

Shave Biopsy

Shave biopsy removes a disc of tissue from the epidermis and superficial to mid-dermis using a tangential cutting motion. Techniques range from superficial shave (razor blade/DermaBlade) to deep saucerization (scoop shave) that extends into the reticular dermis. Technique: raise a wheal of local anesthetic beneath the lesion to create a platform, stabilize the skin with the non-dominant hand, and use a DermaBlade, flexible razor blade, or #15 blade held parallel to the skin surface. The blade is drawn across with a smooth, sawing motion. For saucerization, angle the blade slightly downward to capture deeper tissue. Hemostasis is achieved with aluminum chloride 20% (Drysol) or electrodesiccation.

Clinical Pearls

  • A generous saucerization shave that extends into the reticular dermis is preferred for suspected BCC. It provides adequate depth to identify subtype and avoids the need for repeat biopsy
  • For pigmented lesions suspicious for melanoma, a deep saucerization or excisional biopsy is preferred to capture the full depth for accurate Breslow measurement
  • Bending a flexible razor blade into a slight curve allows better control of depth and creates a naturally saucerized specimen

Important Warnings

  • A superficial shave biopsy that transects a melanoma may render the Breslow thickness unmeasurable. If melanoma is in the differential, perform a deep saucerization that extends well below the visible lesion
  • Avoid ferric subsulfate on biopsy sites that may require Mohs or re-excision. The pigment artifact can be confused with melanin on frozen sections

Incisional Biopsy

Incisional biopsy removes a representative wedge or ellipse of tissue from a larger lesion, sampling through the full depth of the dermis and into the subcutis. It is indicated when the clinical differential includes entities requiring deep tissue sampling (panniculitis, deep fungal infection, morphea) or when the lesion is too large for complete excisional biopsy. Technique: orient the incision to facilitate future definitive excision. Include both abnormal and adjacent normal tissue at the lesion border. Ensure the biopsy extends to the subcutis for adequate depth. Close in layers.

Key Points

  • Incisional biopsy samples a portion of the lesion. A negative result does not exclude malignancy in the unsampled tissue
  • For suspected dermatofibrosarcoma protuberans (DFSP), biopsy must include subcutaneous fat to demonstrate the characteristic honeycomb infiltration pattern

Elliptical (Fusiform) Excision

The elliptical excision is the most commonly performed procedure in dermatologic surgery. Mastery of its design principles. The 3:1 length-to-width ratio, RSTL alignment, appropriate margins, and efficient closure. Is essential for every cutaneous surgeon.

Design Principles

The fusiform excision is designed as an elongated ellipse with pointed tips at 30-degree angles. The standard 3:1 length-to-width ratio ensures that the wound can be closed without standing cutaneous deformities (dog ears) at the tips. Shorter ratios (2:1) create dog ears; longer ratios (4:1) remove excess tissue unnecessarily. Alignment: the long axis should be parallel to the RSTLs whenever possible. On the face, this typically follows expression lines. Margin marking: use a ruler to mark the desired clinical margin around the tumor, then design the ellipse around the marked margin. Never let the ellipse shape compromise the margin width.

Clinical Pearls

  • The 3:1 rule is a starting guideline. On convex surfaces (nose tip, scalp), shorter ellipses may close without dog ears due to the curvature distributing tension
  • On the face, cosmetic subunit boundaries may dictate excision orientation that differs from strict RSTL alignment. Scars at subunit junctions are less conspicuous
Design Principles
Tumor / ScenarioRecommended MarginRationale
Low-risk BCC (L/M-zone, nodular)4mm95% clearance rate (Bauer et al.)
High-risk BCC (H-zone, aggressive subtype)Mohs preferredStandard margins insufficient for subclinical extension
Low-risk SCC (<2cm, well-differentiated)4–6mmNCCN v1.2026 recommendation
High-risk SCCMohs preferredSubclinical extension 3–7mm common (Brodland & Zitelli)
Melanoma in situ5–9mmPer NCCN v1.2026; 5mm standard, up to 9mm acceptable
Melanoma ≤1mm Breslow1cmNCCN v1.2026
Melanoma 1.01–2mm Breslow1–2cmNCCN v1.2026
Benign lesion (cyst, lipoma)Minimal (1–2mm)Complete removal without wide margins

Surgical Technique

Excision begins with scoring the planned ellipse with the #15 blade tip to create a visible guideline. The incision is then carried through with the blade held perpendicular to the skin surface along the lateral margins, transitioning to a 30-degree angle at the tips to create the pointed ends. The tissue is elevated from one tip using skin hooks (never crush the specimen with toothed forceps), and the subcutis is incised with the blade angled slightly inward. Undermining: performed in the subcutaneous fat (above the fascia) using blunt dissection with scissors or sharp dissection with the blade. Undermine 1–2cm beyond each wound edge to reduce closure tension. On the face, undermine in a plane superficial to the muscular aponeurotic layer. Hemostasis with electrocautery before closure.

Key Points

  • Always hold the blade perpendicular to the skin at the lateral margins. Angling the blade creates beveled edges that are difficult to evert during closure
  • Undermine in a uniform plane to create equal flap thickness. Uneven undermining creates contour irregularities
  • Use skin hooks, not forceps, on the specimen edge to avoid crush artifact that can compromise histopathologic interpretation

Dog Ear Management

Standing cutaneous deformities (dog ears) are mounds of redundant tissue at the tips of an elliptical closure. They occur when the length-to-width ratio is insufficient or when wound edges have unequal lengths. Standard repair technique: extend the incision beyond the dog ear in the direction of the planned scar line. Hook or elevate the redundant tissue mound, incise one side at a 45–60-degree angle to create a triangular excision, then trim the opposite side to match. M-plasty: an alternative that shortens the overall scar by converting each tip into a small M shape. Useful when the standard ellipse would cross an anatomic landmark (eyebrow, hairline, vermilion border). Rule of thumb: small dog ears in thick skin (scalp, back) often flatten with time and wound maturation. Observe for 3–6 months before revising.

Clinical Pearls

  • Many small dog ears resolve spontaneously as the wound matures over 3–6 months. Resist the urge to revise immediately, especially on the trunk
  • The M-plasty is invaluable when an ellipse would otherwise cross the vermilion border, eyebrow, or hairline. It shortens the total scar length by 30–40%

Curettage & Electrodesiccation (C&E)

Curettage and electrodesiccation is a destructive technique used for select low-risk skin cancers and benign lesions. The procedure relies on the differential texture between tumor and normal dermis. The soft, friable tumor is curetted away, while the firm normal dermis resists the curette, providing a tactile endpoint.

Technique

The standard protocol involves 2–3 cycles of curettage followed by electrodesiccation: Cycle 1: Curette the visible tumor using firm, systematic strokes in multiple directions. The curette catches on and scoops out the soft tumor tissue until the firm, gritty texture of normal dermis is felt throughout the base and edges. Apply electrodesiccation to the curetted base to char a 1mm layer. Cycle 2–3: Repeat curettage of the charred tissue and an additional 2–3mm margin of surrounding normal skin. The wound heals by secondary intention over 4–8 weeks.

Clinical Pearls

  • The curettage phase is more important than the electrodesiccation. It is the tactile distinction between tumor and normal dermis that defines the treatment extent
  • 3 cycles of C&E improve cure rates compared to 1–2 cycles. The additional passes catch residual tumor at the margins
  • Use the largest curette that fits the lesion (typically 4–7mm) for the first pass, then switch to a smaller curette (2–3mm) for subsequent passes to clean margins

Patient & Tumor Selection

C&E achieves cure rates of 92–97% for appropriately selected tumors but drops to 50–80% when used for inappropriate indications. Strict patient selection is critical.

Important Warnings

  • Never use C&E in the H-zone (central face, eyelids, nose, lips, ears, temple). The lack of margin control and high recurrence risk make it inappropriate for these cosmetically and functionally critical areas
  • C&E should not be used for aggressive BCC subtypes (infiltrative, morpheaform, micronodular). These tumors have irregular extensions that the curette cannot reliably detect
  • C&E does not provide a histologic specimen for margin assessment. There is no way to confirm complete removal
Patient & Tumor Selection
Appropriate for C&ENOT Appropriate for C&E
Primary, well-defined BCCRecurrent BCC (any location)
Nodular or superficial subtypeInfiltrative, morpheaform, micronodular subtype
Trunk or extremities (L-zone)H-zone (face, ears, nose, lips, periorbital)
Small size (<1cm preferred)Large tumors (>2cm)
Immunocompetent patientImmunosuppressed patient
No prior treatment at sitePreviously treated/recurrent site (scar tissue)
Low-risk SCC (well-diff, <1cm, L-zone)High-risk SCC (any criterion)
References
  1. [1] NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer v1.2026. NCCN Guidelines. .
  2. [2] NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer v1.2026. NCCN Guidelines. .
  3. [3] Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. . doi:10.1067/mjd.2001.112401
  4. [4] Surgical technique for optimal outcomes: Part I. Cutting, handling, and suturing tissue. J Am Acad Dermatol. . doi:10.1016/j.jaad.2015.02.1143

About This Article

Author: , Fellow ACMS

Last Medical Review:

Audience: Dermatologic Surgeons

Clinic: Kaplan Clinic · DermUnbound Research Program

Educational content only. This material does not replace hands-on training, mentorship, or institutional protocols. All clinical decisions remain the responsibility of the treating physician.